• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

透明细胞卵巢癌的扩散模式：病例报告与病例系列

Patterns of spread of clear cell ovarian cancer: Case report and case series.

作者信息

Kumar Aalok, Gilks C Blake, Mar Colin, Santos Jennifer, Tinker Anna V

机构信息

Division of Medical Oncology, Vancouver Centre, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5N4E6, Canada.

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

出版信息

Gynecol Oncol Case Rep. 2013 Aug 3;6:25-7. doi: 10.1016/j.gynor.2013.07.008. eCollection 2013.

DOI:10.1016/j.gynor.2013.07.008
PMID:24371712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3862223/
Abstract

•Although patterns of metastases in ovarian clear cell cancer are not well described, patients may initially present with bone metastases.•Clear cell carcinoma with bone metastases is responsive to radiation therapy.•Bone metastases are not common in patients with ovarian high grade serous cancer.

摘要

•虽然卵巢透明细胞癌的转移模式尚无详尽描述，但患者最初可能表现为骨转移。

•伴有骨转移的透明细胞癌对放射治疗有反应。

•骨转移在卵巢高级别浆液性癌患者中并不常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/3862223/f6162fa48596/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/3862223/9915692b76c3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/3862223/f6162fa48596/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/3862223/9915692b76c3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/3862223/f6162fa48596/gr2.jpg

相似文献

1
Patterns of spread of clear cell ovarian cancer: Case report and case series.透明细胞卵巢癌的扩散模式：病例报告与病例系列
Gynecol Oncol Case Rep. 2013 Aug 3;6:25-7. doi: 10.1016/j.gynor.2013.07.008. eCollection 2013.
2
Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.卵巢和腹膜浆液性癌伴乳腺及腋窝淋巴结转移：一个潜在的陷阱。
Am J Surg Pathol. 2004 Dec;28(12):1646-51. doi: 10.1097/00000478-200412000-00015.
3
Cell Origins of High-Grade Serous Ovarian Cancer.高级别浆液性卵巢癌的细胞起源
Cancers (Basel). 2018 Nov 12;10(11):433. doi: 10.3390/cancers10110433.
4
Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.pStage 1期低级别浆液性卵巢肿瘤出现有症状的骨转移的晚期复发：一例报告
Diagn Pathol. 2018 Jun 30;13(1):43. doi: 10.1186/s13000-018-0720-1.
5
From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.从克鲁肯伯格瘤到如今：卵巢转移性肿瘤带来的长期存在的问题。第二部分。
Adv Anat Pathol. 2007 May;14(3):149-77. doi: 10.1097/PAP.0b013e3180504abf.
6
[Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].[输卵管伞端上皮内癌与盆腔高级别浆液性癌关系的初步研究]
Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):724-8.
7
[Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].[HNF-1β与Napsin A联合检测在卵巢透明细胞癌诊断中的诊断价值]
Zhonghua Bing Li Xue Za Zhi. 2015 Dec;44(12):874-8.
8
High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.伴有黏液样分化的高级别浆液性卵巢癌：1例罕见且独特病例报告，提示从高级别浆液性癌的“SET”特征向“STEM”特征转变
Diagn Pathol. 2019 Jan 12;14(1):4. doi: 10.1186/s13000-019-0781-9.
9
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.Napsin A和WT 1是用于鉴别卵巢透明细胞癌与高级别浆液性癌的有用免疫组化标志物。
APMIS. 2018 Jan;126(1):45-55. doi: 10.1111/apm.12784. Epub 2017 Nov 20.
10
The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.雌激素受体和孕激素受体的阳性表达可能与上皮性卵巢癌的转移和复发无关。
Sci Rep. 2017 Dec 5;7(1):16922. doi: 10.1038/s41598-017-17265-6.

引用本文的文献

1
Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma.卵巢透明细胞癌发病机制、诊断与治疗前景的最新进展
J Cancer. 2021 Feb 22;12(8):2295-2316. doi: 10.7150/jca.53395. eCollection 2021.
2
Utility of adjuvant whole abdominal radiation therapy in ovarian clear cell cancer (OCCC): a pragmatic cohort study of women with classic immuno-phenotypic signature.辅助性全腹部放疗在卵巢透明细胞癌（OCCC）中的作用：具有典型免疫表型特征的女性的实用队列研究。
Radiat Oncol. 2021 Feb 6;16(1):29. doi: 10.1186/s13014-021-01750-4.
3
Ovarian Cancer Dissemination-A Cell Biologist's Perspective.

本文引用的文献

1
Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.低分期卵巢透明细胞癌：加拿大不列颠哥伦比亚省的基于人群的结局，有证据表明放疗可带来生存获益。
J Clin Oncol. 2012 May 10;30(14):1656-62. doi: 10.1200/JCO.2011.40.1646. Epub 2012 Apr 9.
2
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.探讨晚期或复发性卵巢透明细胞癌女性的姑息治疗结局。
Gynecol Oncol. 2011 Jul;122(1):107-10. doi: 10.1016/j.ygyno.2011.03.011. Epub 2011 Apr 3.
3
Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers.
卵巢癌的播散——细胞生物学家的视角
Cancers (Basel). 2019 Dec 6;11(12):1957. doi: 10.3390/cancers11121957.
4
Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases.伴有双侧乳腺转移的卵巢透明细胞癌。
Case Rep Oncol Med. 2019 Apr 28;2019:8013913. doi: 10.1155/2019/8013913. eCollection 2019.
5
Biological intensity-modulated radiotherapy plus neoadjuvant chemotherapy for multiple peritoneal metastases of ovarian cancer: A case report.生物调强放疗联合新辅助化疗治疗卵巢癌多发腹膜转移：1例病例报告
Oncol Lett. 2015 Mar;9(3):1239-1243. doi: 10.3892/ol.2014.2820. Epub 2014 Dec 22.
组织学分型预测放疗的疗效潜力：以卵巢癌为例。
Ann Oncol. 2011 Feb;22(2):341-7. doi: 10.1093/annonc/mdq383. Epub 2010 Aug 6.
4
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.卵巢癌亚型是不同的疾病：对生物标志物研究的启示。
PLoS Med. 2008 Dec 2;5(12):e232. doi: 10.1371/journal.pmed.0050232.
5
Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary.卵巢透明细胞腺癌的术后全腹放疗
Gynecol Oncol. 2007 Dec;107(3):469-73. doi: 10.1016/j.ygyno.2007.07.079. Epub 2007 Aug 31.
6
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.晚期透明细胞上皮性卵巢癌：希腊肿瘤协作组的经验
Gynecol Oncol. 2006 Aug;102(2):285-91. doi: 10.1016/j.ygyno.2005.12.038. Epub 2006 Mar 3.
7
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.卵巢透明细胞癌的临床特征：一种预后不良且对铂类化疗耐药的独特组织学类型。
Cancer. 2000 Jun 1;88(11):2584-9.
8
Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy.与非铂类化疗相比，铂类化疗治疗的卵巢透明细胞癌患者生存率未提高且血栓栓塞并发症增加。
Cancer. 1996 Nov 15;78(10):2157-63. doi: 10.1002/(sici)1097-0142(19961115)78:10<2157::aid-cncr17>3.0.co;2-y.
9
Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma.卵巢透明细胞腺癌：临床分析及与浆液性癌的比较
Gynecol Oncol. 1989 Jan;32(1):65-71. doi: 10.1016/0090-8258(89)90852-4.
10
Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases.
Int J Gynecol Pathol. 1989;8(2):85-96. doi: 10.1097/00004347-198906000-00001.